Back to Agenda
The Sites Have Spoken: Implementing Paperless Trials and Risk-Based Monitoring from a Site’s Perspective
Session Chair(s)
Penelope K. Manasco, MD, MS
Chief Executive Officer, MANA RBM , United States
This session brings sites that have adopted paperless trials together to provide their opinions and insights into this new approach to clinical trial conduct.
Learning Objective : Identify key factors for the successful adoption of paperless trials for investigative sites; Discuss key technology components and their setup that assist sites in the adoption of technology; Describe key training features that ensure adoption by the sites.
Speaker(s)
Mary R. Flack, MD
Clinical Program Leader, Immunology, Boehringer-Ingelheim , United States
Site Satisfaction with a P3 Paperless Clinical Trial
Catherine Morimoto
Director of Clinical Operations, Diablo Clinical Research, United States
A Site's Experience with Implementing Electronic Source
Teresa Suek
President, Research 3, Inc., United States
Implementing eSource for Home Visits by Home Health Nurses
Have an account?